DeepMed Research

St. Jude Children's Research Hospital

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1962-01-01

Employees: -

Market Cap: -

Website: http://www.stjude.org/

Clinical Trials

Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease

Completed

Conditions: Sickle Cell Disease

First Posted Date: 2006-03-21

Last Posted Date: 2020-07-28

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 260

Registration Number: NCT00305175

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias

Not Applicable

Completed

Conditions: Diamond-Blackfan Anemia
Kostmann Syndrome
Amegakaryocytic Thrombocytopenia
Anemia, Aplastic

Interventions: Device: Allogeneic stem cell transplant

First Posted Date: 2005-10-25

Last Posted Date: 2017-05-30

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 4

Registration Number: NCT00244010

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Study for Treatment of Cancer in Children With Ataxia-telangiectasia

Not Applicable

Completed

Conditions: Ataxia-Telangiectasia

Interventions: Drug: vinblastine, vincristine, prednisone, daunorubicin
Drug: doxorubicin, methotrexate, cyclophosphamide, L-asparaginase
Drug: etoposide, cytarabine, mercaptopurine
Drug: dexamethasone, procarbazine
Procedure: chemotherapy, intrathecal chemotherapy, steroid therapy

First Posted Date: 2005-09-16

Last Posted Date: 2015-08-27

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 6

Registration Number: NCT00187057

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Natural Killer (NK) Cell Transplantation for AML

Not Applicable

Completed

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Cyclophosphamide, Fludarabine, Clofarabine, Etoposide, Interleukin-2
Procedure: Natural Killer Cell Infusion
Device: CliniMACS System

First Posted Date: 2005-09-16

Last Posted Date: 2014-06-19

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 49

Registration Number: NCT00187096

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor

Phase 2

Completed

Conditions: Wilms Tumor

Interventions: Drug: Topotecan, Filgrastim (G-CSF), Pegfilgrastim

First Posted Date: 2005-09-16

Last Posted Date: 2008-06-04

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 37

Registration Number: NCT00187031

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇨🇦
Hospital of Sick Children, Toronto, Ontario, Canada
🇨🇦
Tom Baker Cancer Center, Calgary, Alberta, Canada

and more 4 locations

Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase 2

Completed

Conditions: Acute Lymphoblastic Leukemia
Lymphoma, Lymphoblastic

Interventions: Drug: Etoposide, cytarabine, vincristine, dexamethasone
Drug: methotrexate, teniposide, PEG-asparaginase
Drug: mitoxantrone, cyclophosphamide, mercaptopurine, vinblastine
Drug: L-asparaginase, erwinia asparaginase
Procedure: chemotherapy, intrathecal chemotherapy, steroid therapy
Procedure: Hematopoietic Stem Cell Transplant
Procedure: Natural Killer (NK) Cell Transplant

First Posted Date: 2005-09-16

Last Posted Date: 2017-07-28

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 47

Registration Number: NCT00186875

Locations: 🇺🇸
Rady Children's Hospital and Health Center, San Diego, California, United States
🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Radiation Therapy to Treat Musculoskeletal Tumors

Phase 2

Active, not recruiting

Conditions: Sarcoma, Ewing's
Musculoskeletal Tumors
Soft Tissue Sarcoma
Rhabdomyosarcoma

Interventions: Radiation: image-guided radiotherapy

First Posted Date: 2005-09-16

Last Posted Date: 2025-03-06

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 202

Registration Number: NCT00186992

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients

Completed

Conditions: Leukemia
Lymphoma
Tumor Lysis Syndrome
Hyperuricemia

Interventions: Drug: Rasburicase

First Posted Date: 2005-09-16

Last Posted Date: 2017-04-25

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 16

Registration Number: NCT00186940

Locations: 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Stanford University, Palo Alto, California, United States

and more 8 locations

Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors

Phase 1

Completed

Conditions: Tumors
Rhabdomyosarcoma
Sarcoma, Soft Tissue
Brain Tumors

Interventions: Drug: Everolimus

First Posted Date: 2005-09-16

Last Posted Date: 2015-03-04

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 41

Registration Number: NCT00187174

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects

Phase 2

Completed

Conditions: Brain Tumors
Central Nervous System Tumors

Interventions: Procedure: Radiation Therapy

First Posted Date: 2005-09-16

Last Posted Date: 2023-05-31

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 361

Registration Number: NCT00187226

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy